Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TROPICAL CALCIFIC PANCREATITIS
|
13 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Type 2 diabetes mellitus in obese
|
4 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Fasting blood glucose measurement
|
212 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.800 | 1.000 | 5 | 2009 | 2019 | ||||||
Impaired insulin secretion
|
14 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2009 | 2010 | ||||||
Atherogenic dyslipidaemia
|
9 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Autoantibody measurement
|
52 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||
Cystic Fibrosis
|
704 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Neoplasms
|
1644 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Premature adrenarche
|
11 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Hypertriglyceridemia
|
169 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||||
Prostate carcinoma
|
1168 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||||
Cerebrovascular accident
|
591 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2011 | 2014 | ||||||
Kidney Diseases
|
140 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2014 | ||||||
Schizophrenia
|
2897 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.710 | 1.000 | 2 | 2011 | 2018 | ||||||
Diabetes in youth
|
2 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Insulin measurement
|
25 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.800 | 1.000 | 1 | 2011 | 2011 | ||||||
Transient Cerebral Ischemia
|
9 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Transient Ischemic Attack
|
16 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Body mass index
|
2689 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.800 | 1.000 | 9 | 2012 | 2019 | ||||||
Breast Carcinoma
|
2793 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.060 | 1.000 | 6 | 2012 | 2018 | ||||||
Malignant neoplasm of breast
|
3417 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.060 | 1.000 | 6 | 2012 | 2018 | ||||||
Fasting blood sugar result
|
113 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 2 | 2012 | 2012 | ||||||
Malignant Neoplasms
|
1641 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||||
Primary malignant neoplasm
|
1374 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2016 |